Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07460765) titled 'Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Vanderbilt-Ingram Cancer Center
Condition:
Hnscc
Head and Neck
Squamous Cell Cancer
Squamous Carcinoma
Squamous Cell Cancer of Head and Neck (SCCHN)
Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)
Squamous Cell Carcinoma Mouth
Squamous Carcinoma Poorly Differentiated
Squamous Cell Cancer of the Head...